12th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies
5/1/21, 11:00 AM
America/Los_Angeles (PT) -7
Previous registration necessary?
Simultaneous translation ?
Will it be recorded?
Robert L. Coleman, Ursula A. Matulonis, Bradley J. Monk
Welcome, Introductions, Presession Survey, Genetics, Genomics, and Precision Medicine: Efficient Integration of Powerful Tools in Ovarian Cance, Advances in Frontline Treatment Options for Patients With Ovarian Cancer, Novel Strategies in Relapsed/Refractory Ovarian Cancer, Incorporating Combination Therapy in an Evolving Treatment Landscape, Low-Grade Serious Ovarian Cancer, Interactive Cases and Expert Discussion in Ovarian Cancer, IO in Ovarian Cancer, IO in Cervical Cancer, IO in Endometrial Cancer, Impact of Biomarker Testing on Precision Medicine for Cervical Cancer, Sequencing Therapies for Cervical Cancer and Future Directions Beyond IO, Medical Crossfire®: What’s the Best Treatment for Homologous Recombination–Proficient Ovarian Cancer, Can Biomarker Testing Inform Treatment Decision-Making in Endometrial Cancer?, Non-IO Treatments for Endometrial Cancer, Interactive Cases and Expert Discussion in Cervical and Endometrial Cancers, Closing Remarks, Adjourn
Bradley J. Monk, Michael Birrer, Kathleen Moore, Nicoletta Colombo, Rachel Grisham, Eric Pujade-Lauraine, Ana Oaknin, Mansoor Raza Mirza, Ritu Salani, Leslie Randall, Ursula A. Matulonis, Gottfried Konecny, David O'Malley, Ramez Eskander, Brian Slomovitz